Healthcare provider profile · identity verified

Iveth Soza, D.O.

Family Practice · SAN ANTONIO, TX · NPI 1467421875

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	806	269
Amlodipine Besylate	Amlodipine Besylate	498	152
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	415	104
Levothyroxine Sodium	Levothyroxine Sodium	414	125
Metformin Hcl	Metformin Hcl	377	124
Gabapentin	Gabapentin	363	126
Tramadol Hcl	Tramadol Hcl	325	104
Lisinopril	Lisinopril	294	92
Enalapril Maleate	Enalapril Maleate	267	90
Losartan Potassium	Losartan Potassium	251	82
Ozempic	Semaglutide	240	49
Albuterol Sulfate Hfa	Albuterol Sulfate	221	97
Metoprolol Succinate	Metoprolol Succinate	204	70
Simvastatin	Simvastatin	201	62
Omeprazole	Omeprazole	197	62
Tamsulosin Hcl	Tamsulosin Hcl	182	64
Furosemide	Furosemide	163	52
Fluticasone Propionate	Fluticasone Propionate	158	63
Clonazepam	Clonazepam	151	35
Glipizide	Glipizide	145	49
Triamcinolone Acetonide	Triamcinolone Acetonide	138	75
Montelukast Sodium	Montelukast Sodium	136	43
Sertraline Hcl	Sertraline Hcl	132	45
Carvedilol	Carvedilol	127	40
Alprazolam	Alprazolam	122	48
Alendronate Sodium	Alendronate Sodium	118	38
Rosuvastatin Calcium	Rosuvastatin Calcium	115	37
Potassium Chloride	Potassium Chloride	108	34
Famotidine	Famotidine	107	43
Meloxicam	Meloxicam	106	36
Ondansetron Hcl	Ondansetron Hcl	103	48
Metoprolol Tartrate	Metoprolol Tartrate	99	32
Hydrochlorothiazide	Hydrochlorothiazide	98	40
Pantoprazole Sodium	Pantoprazole Sodium	98	24
Olmesartan Medoxomil	Olmesartan Medoxomil	96	30
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	95	38
Pioglitazone Hcl	Pioglitazone Hcl	94	36
Nifedipine Er	Nifedipine	84	16
Pravastatin Sodium	Pravastatin Sodium	80	25
Myrbetriq	Mirabegron	79	23
Trazodone Hcl	Trazodone Hcl	76	26
Bupropion Hcl Sr	Bupropion Hcl	72	18
Farxiga	Dapagliflozin Propanediol	72	25
Pregabalin	Pregabalin	71	23
Citalopram Hbr	Citalopram Hydrobromide	70	29
Naproxen	Naproxen	70	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	21
Azithromycin	Azithromycin	68	60
Tizanidine Hcl	Tizanidine Hcl	65	13
Mounjaro	Tirzepatide	64	20
Allopurinol	Allopurinol	63	15
Eliquis	Apixaban	63	18
Escitalopram Oxalate	Escitalopram Oxalate	62	23
Finasteride	Finasteride	61	19
Clopidogrel	Clopidogrel Bisulfate	58	22
Hydroxyzine Hcl	Hydroxyzine Hcl	58	17
Lorazepam	Lorazepam	58	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	18
Jardiance	Empagliflozin	55	18
Mirtazapine	Mirtazapine	55	22
Duloxetine Hcl	Duloxetine Hcl	54	18
Hydralazine Hcl	Hydralazine Hcl	54	16
Prednisone	Prednisone	54	21
Januvia	Sitagliptin Phosphate	53	14
Sucralfate	Sucralfate	53	18
Fluoxetine Hcl	Fluoxetine Hcl	50	13
Ibuprofen	Ibuprofen	50	22
Acetaminophen-Codeine	Acetaminophen With Codeine	48	28
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	48	16
Meclizine Hcl	Meclizine Hcl	48	18
Ketoconazole	Ketoconazole	47	16
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Testosterone Cypionate	Testosterone Cypionate	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	31
Clobetasol Propionate	Clobetasol Propionate	41	27
Benazepril Hcl	Benazepril Hcl	40	11
Cefdinir	Cefdinir	40	29
Liothyronine Sodium	Liothyronine Sodium	40	12
Xarelto	Rivaroxaban	38	suppressed
Methylprednisolone	Methylprednisolone	37	33
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	36	27
Metformin Hcl Er	Metformin Hcl	35	11
Hydrocortisone	Hydrocortisone	34	12
Nystatin	Nystatin	34	13
Spironolactone	Spironolactone	34	suppressed
Valsartan	Valsartan	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	23
Fluconazole	Fluconazole	32	22
Oxybutynin Chloride	Oxybutynin Chloride	32	11
Solifenacin Succinate	Solifenacin Succinate	31	13
Baclofen	Baclofen	30	13
Propranolol Hcl	Propranolol Hcl	30	suppressed
Levemir Flexpen	Insulin Detemir	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Acyclovir	Acyclovir	27	13
Clonidine	Clonidine	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	12
Lidocaine	Lidocaine	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Bupropion Hcl	Bupropion Hcl	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Topiramate	Topiramate	24	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	23	suppressed
Cephalexin	Cephalexin	23	17
Comfort Ez Pen Needle	Pen Needle, Diabetic	23	suppressed
Lactulose	Lactulose	23	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Aripiprazole	Aripiprazole	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	20
Belsomra	Suvorexant	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Constulose	Lactulose	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Progesterone	Progesterone, Micronized	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Testosterone	Testosterone	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Temazepam	Temazepam	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Primidone	Primidone	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error